{
    "organizations": [],
    "uuid": "96b98a8be2d642d26d0e6b6d5a6f8a84a029127b",
    "author": "",
    "url": "https://www.reuters.com/article/brief-merck-and-viralytics-announce-acqu/brief-merck-and-viralytics-announce-acquisition-agreement-idUSASB0C6L1",
    "ord_in_thread": 0,
    "title": "BRIEF-Merck And Viralytics Announce Acquisition Agreement",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 14 AM / Updated 38 minutes ago BRIEF-Merck And Viralytics Announce Acquisition Agreement Reuters Staff Feb 21 (Reuters) - Merck & Co Inc: * MERCK AND VIRALYTICS ANNOUNCE ACQUISITION AGREEMENT, EXPANDING MERCKâ€˜S LEADING IMMUNO-ONCOLOGY PIPELINE * MERCK - PROPOSED ACQUISITION VALUES THE TOTAL ISSUED SHARES IN VIRALYTICS AT APPROXIMATELY AUD 502 MILLION (USD 394 MILLION) * MERCK - ON COMPLETION OF TRANSACTION, VIRALYTICS WILL BECOME A WHOLLY-OWNED SUBSIDIARY OF MERCK Source text for Eikon: Further company coverage:",
    "published": "2018-02-21T11:13:00.000+02:00",
    "crawled": "2018-02-21T11:35:07.006+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "updated",
        "minute",
        "ago",
        "viralytics",
        "announce",
        "acquisition",
        "agreement",
        "reuters",
        "staff",
        "feb",
        "reuters",
        "merck",
        "co",
        "inc",
        "merck",
        "viralytics",
        "announce",
        "acquisition",
        "agreement",
        "expanding",
        "merck",
        "leading",
        "pipeline",
        "merck",
        "proposed",
        "acquisition",
        "value",
        "total",
        "issued",
        "share",
        "viralytics",
        "approximately",
        "aud",
        "million",
        "usd",
        "million",
        "merck",
        "completion",
        "transaction",
        "viralytics",
        "become",
        "subsidiary",
        "merck",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}